Call Options Transactions Made in Q3 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q3 2024. The information is specifically focused on institutions that hold call options of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
63KNew |
$524K - $693K
|
63K
$889K
|
|
|
Nov 13, 2024
Q3 2024
|
Myda Advisors LLC
Inwood, NY |
BUY
|
CALL |
50KNew |
$416K - $550K
|
50K
$706K
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
30.7K+ 41.32% |
$255K - $338K
|
105K
$1.48M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
17.7K+ 10.91% |
$147K - $195K
|
180K
$2.54M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
9.4K+ 11.71% |
$78.2K - $103K
|
89.7K
$1.27M
|
|
|
Nov 13, 2024
Q3 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
CALL |
-4.75M- 95.0% |
$39.5M - $52.3M
|
250K
$3.53M
|